Cancer Lett

• 

  Publication Venue For

  • Heterogeneity and vascular permeability of breast cancer brain metastases..  489:174-181. 2020
  • 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces peripheral blood abnormalities and plasma cell neoplasms resembling multiple myeloma in mice..  440-441:135-144. 2019
  • Pan-PIM kinase inhibitors enhance Lenalidomide's anti-myeloma activity via cereblon-IKZF1/3 cascade..  440-441:1-10. 2019
  • CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis..  430:179-192. 2018
  • Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells..  411:136-149. 2017
  • A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer..  403:13-20. 2017
  • Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism..  385:12-20. 2017
  • Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6..  384:1-8. 2017
  • eIF4E-phosphorylation-mediated Sox2 upregulation promotes pancreatic tumor cell repopulation after irradiation..  375:31-38. 2016
  • Epigenetic silencing of Kruppel like factor-3 increases expression of pro-metastatic miR-182..  369:202-211. 2015
  • Epigenetics and cancer metabolism..  356:309-314. 2015
  • Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer..  347:204-211. 2014
  • The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth..  343:51-61. 2014
  • Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization..  337:77-89. 2013
  • Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx..  330:233-240. 2013
  • Interferon Regulatory Factor 1 (IRF-1) induces p21(WAF1/CIP1) dependent cell cycle arrest and p21(WAF1/CIP1) independent modulation of survivin in cancer cells..  319:56-65. 2012
  • Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations..  318:124-134. 2012
  • EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity..  294:101-110. 2010
  • ERCC6/CSB gene polymorphisms and lung cancer risk..  273:172-176. 2009
  • Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer..  272:32-39. 2008
  • Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer..  270:173-180. 2008
  • PAX3-FOXO1 fusion gene in rhabdomyosarcoma..  270:10-18. 2008